ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 124

Pharmacist Role in an Outpatient Adolescent Complex Pediatric Lupus Clinic

Shannon Rotolo 1, Grace Cameron2, Cuoghi Edens 1 and Constentina Talevski 3, 1UCM, Chicago, 2UCM, Oak Lawn, 3Univeristy of Chicago Medicine, Lockport

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: Pharmacists, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Saturday, May 2, 2020

Title: Poster Session 3

Session Type: ACR Abstract Session

Session Time: 4:15PM-5:15PM

Background/Purpose: Systemic lupus erythematous (SLE) is an autoimmune disease in which the body produces pathogenic autoantibodies that cause inflammation resulting in multi-organ damage. A SLE diagnosis in childhood or adolescence often equates to more severe disease with higher renal, neurologic and hematologic involvement than adults. Children with pediatric SLE often require complex regimens of immunosuppressive medications to control the disease and prevent flares. In recent years, the incorporation of pharmacists as a part of the care team for patients with chronic conditions, including cystic fibrosis and HIV, has been described. Pharmacists have been shown to improve patient and physician satisfaction, improve patients’ medication understanding and adherence, and decrease medication related errors. The University of Chicago Medicine (UCM) Comer Children’s Hospital established a complex lupus clinic in January 2019 with a multidisciplinary care team which includes a clinical pharmacist. Although there is some literature on pharmacist interactions and interventions with rheumatology patients, this is confined primarily to inpatient or specialty pharmacy settings. The purpose of this project is to describe the pharmacist role in a multidisciplinary pediatric lupus clinic and the impact it has on patient care.

Methods: Patients were scheduled for 15-30 minutes with the pharmacist as part of their extended clinic appointment. Pharmacist assessments were performed at initial and follow-up visits, and included a medication reconciliation, adherence review, and medication management tasks review. Patients and caregivers were given the opportunity to ask questions as well as provided a pill box. If appropriate, medication management task “homework” was assigned. All patients were offered the option of transferring their prescriptions to the on-site outpatient pharmacy and eligible patients enrolled in financial assistance programs.

Results: Among the 34 patients seen by a pharmacist during clinic appointments, median age was 16 years old, 88.2% were female, and 47.1% were black. Additional patient demographic information is presented in Table 1. At the time of the first appointment, only 67.7% of patient or caregivers reported already having a relationship with a pharmacist. Adherence assessment data is reported in Table 2. Medication management task completion by patients is reported in Table 3. The most common pharmacist education topics were review of indications for drug(s) and bone health recommendations. The most common pharmacist interventions were weight-based dose adjustment of hydroxychloroquine and de-escalation of long-standing stress ulcer prophylaxis regimens.

Conclusion: Our initial findings demonstrate that pharmacists involvement in a multidisciplinary pediatric lupus clinic can improve patient’s understanding of non-pharmacologic and pharmacological therapies, improve patient adherence, and provide support to patients as they take on additional medication management tasks.


Disclosure: S. Rotolo, None; G. Cameron, None; C. Edens, None; C. Talevski, None.

To cite this abstract in AMA style:

Rotolo S, Cameron G, Edens C, Talevski C. Pharmacist Role in an Outpatient Adolescent Complex Pediatric Lupus Clinic [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/pharmacist-role-in-an-outpatient-adolescent-complex-pediatric-lupus-clinic/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pharmacist-role-in-an-outpatient-adolescent-complex-pediatric-lupus-clinic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology